Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice.

Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice.

Item
http://www.wikidata.org/entity/Q34218811
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy.A quantitative LC-MS/MS method for determination of SP-141, a novel pyrido[b]indole anticancer agent, and its application to a mouse PK study.RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo.Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish.Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.RYBP predicts survival of patients with non-small cell lung cancer and regulates tumor cell growth and the response to chemotherapy.Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapAIdentification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapyInulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapyOral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells.Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas.Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen.Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy.Highly efficient delivery of potent anticancer iminoquinone derivative by multilayer hydrogel cubes.Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer.
P2860

Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice.

Item
http://www.wikidata.org/entity/Q34218811
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of a new class ...... pic pancreatic tumors in mice.
@ast
Identification of a new class ...... pic pancreatic tumors in mice.
@en
Identification of a new class ...... pic pancreatic tumors in mice.
@nl
type
label
Identification of a new class ...... pic pancreatic tumors in mice.
@ast
Identification of a new class ...... pic pancreatic tumors in mice.
@en
Identification of a new class ...... pic pancreatic tumors in mice.
@nl
prefLabel
Identification of a new class ...... pic pancreatic tumors in mice.
@ast
Identification of a new class ...... pic pancreatic tumors in mice.
@en
Identification of a new class ...... pic pancreatic tumors in mice.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Identification of a new class ...... pic pancreatic tumors in mice.
@en
P2093
P2860
P304
P31
P356
10.1053/J.GASTRO.2014.07.001
P407
P433
P478
P50
P577
P5875
P698
P932